JP2023528310A5 - - Google Patents
Info
- Publication number
- JP2023528310A5 JP2023528310A5 JP2022572365A JP2022572365A JP2023528310A5 JP 2023528310 A5 JP2023528310 A5 JP 2023528310A5 JP 2022572365 A JP2022572365 A JP 2022572365A JP 2022572365 A JP2022572365 A JP 2022572365A JP 2023528310 A5 JP2023528310 A5 JP 2023528310A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20176360 | 2020-05-25 | ||
| EP20176360.4 | 2020-05-25 | ||
| PCT/EP2021/063738 WO2021239643A1 (en) | 2020-05-25 | 2021-05-24 | Benzylamine derivatives as ddrs inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023528310A JP2023528310A (ja) | 2023-07-04 |
| JP2023528310A5 true JP2023528310A5 (https=) | 2024-05-30 |
| JPWO2021239643A5 JPWO2021239643A5 (https=) | 2024-05-30 |
| JP7761595B2 JP7761595B2 (ja) | 2025-10-28 |
Family
ID=70847297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572365A Active JP7761595B2 (ja) | 2020-05-25 | 2021-05-24 | Ｄｄｒ阻害物質としてのベンジルアミン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230227447A1 (https=) |
| EP (1) | EP4157447A1 (https=) |
| JP (1) | JP7761595B2 (https=) |
| KR (1) | KR20230016190A (https=) |
| CN (1) | CN115697485B (https=) |
| AU (1) | AU2021282320A1 (https=) |
| BR (1) | BR112022022679A2 (https=) |
| CA (1) | CA3178242A1 (https=) |
| MX (1) | MX2022014295A (https=) |
| WO (1) | WO2021239643A1 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050091462A (ko) | 2004-03-12 | 2005-09-15 | 한국과학기술연구원 | 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제 |
| US7754717B2 (en) * | 2005-08-15 | 2010-07-13 | Amgen Inc. | Bis-aryl amide compounds and methods of use |
| DK2848610T3 (da) * | 2006-11-15 | 2017-11-06 | Ym Biosciences Australia Pty | Hæmmere af kinaseaktivitet |
| KR101126736B1 (ko) | 2008-11-27 | 2012-04-12 | 주식회사 레고켐 바이오사이언스 | 티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물 |
| US9180127B2 (en) * | 2009-12-29 | 2015-11-10 | Dana-Farber Cancer Institute, Inc. | Type II Raf kinase inhibitors |
| MX2014012991A (es) | 2012-04-24 | 2015-08-14 | Chugai Pharmaceutical Co Ltd | Derivado de benzamida. |
| US20150225369A1 (en) | 2012-08-29 | 2015-08-13 | Merck Patent Gmbh | Ddr2 inhibitors for the treatment of osteoarthritis |
| FR3000493A1 (fr) * | 2012-12-28 | 2014-07-04 | Oribase Pharma | Nouveaux inhibiteurs de proteines kinases |
| WO2015004481A1 (en) | 2013-07-11 | 2015-01-15 | Astex Therapeutics Limited | Imidazo-condensed bicycles as inhibitors of discoidin domain receptors (ddrs) |
| JP6307088B2 (ja) | 2013-10-23 | 2018-04-04 | 中外製薬株式会社 | キナゾリノンおよびイソキノリノン誘導体 |
| EP3209299A4 (en) | 2014-10-22 | 2018-04-04 | The Board of Regents of The University of Texas System | Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof |
| EP3317279B1 (en) | 2015-07-03 | 2021-01-27 | H. Hoffnabb-La Roche Ag | Triaza-spirodecanones as ddr1 inhibitors |
| TW201718480A (zh) | 2015-08-31 | 2017-06-01 | 東麗股份有限公司 | 尿素衍生物及其用途 |
-
2021
- 2021-05-24 CN CN202180037706.3A patent/CN115697485B/zh active Active
- 2021-05-24 WO PCT/EP2021/063738 patent/WO2021239643A1/en not_active Ceased
- 2021-05-24 EP EP21726678.2A patent/EP4157447A1/en active Pending
- 2021-05-24 MX MX2022014295A patent/MX2022014295A/es unknown
- 2021-05-24 KR KR1020227043598A patent/KR20230016190A/ko active Pending
- 2021-05-24 US US17/927,762 patent/US20230227447A1/en active Pending
- 2021-05-24 AU AU2021282320A patent/AU2021282320A1/en active Pending
- 2021-05-24 CA CA3178242A patent/CA3178242A1/en active Pending
- 2021-05-24 BR BR112022022679A patent/BR112022022679A2/pt unknown
- 2021-05-24 JP JP2022572365A patent/JP7761595B2/ja active Active